About
Flow Neuroscience is a neurotechnology company based in Malmö, Sweden, co-founded by clinical psychologist Daniel Mansson and neuroscientist Erik Rehn. Established in February 2022, the company specializes in manufacturing electromedical and electrotherapeutic equipment aimed at treating Major Depressive Disorder (MDD). Their core product is a medically certified brain stimulation headset paired with a personalized mobile app, which integrates transcranial direct current stimulation (tDCS) with behavioral therapy. This innovative solution is recognized as the only one with FDA Breakthrough Designation and EU medical device certification. The company focuses on making depression treatment effective, affordable, and accessible, allowing users to engage with the therapy anytime and anywhere. Flow Neuroscience emphasizes scientific rigor and aims to normalize mental health conversations while challenging traditional treatment methods. Their leadership team includes experts in growth, marketing, and finance, and they collaborate with academic advisors from prestigious institutions to ensure clinical validation and scientific excellence. The company is dedicated to improving mental health outcomes through its unique approach to treatment.
Technologies
Keywords
Company Information
-
Employees 38
-
Founded 2016
-
Annual Revenue $5100000
-
Total Funding $11599513
Location
2 Soedra Foerstadsgatan, Malmoe, Skane County, Sweden, 211 43
